CIMAZ, ROLANDO
 Distribuzione geografica
Continente #
NA - Nord America 11.149
EU - Europa 6.942
AS - Asia 4.661
SA - Sud America 534
AF - Africa 159
OC - Oceania 141
Continente sconosciuto - Info sul continente non disponibili 10
Totale 23.596
Nazione #
US - Stati Uniti d'America 10.612
CN - Cina 2.175
GB - Regno Unito 1.891
IT - Italia 1.262
IE - Irlanda 810
SE - Svezia 554
DE - Germania 509
IN - India 454
JP - Giappone 441
HK - Hong Kong 406
FR - Francia 367
CA - Canada 338
TR - Turchia 329
ES - Italia 280
BR - Brasile 198
KR - Corea 187
MX - Messico 175
RU - Federazione Russa 142
AU - Australia 132
NL - Olanda 124
DK - Danimarca 117
VN - Vietnam 114
SG - Singapore 105
AR - Argentina 104
UA - Ucraina 103
BE - Belgio 94
ID - Indonesia 93
PL - Polonia 92
FI - Finlandia 91
GR - Grecia 90
CO - Colombia 87
TW - Taiwan 71
CH - Svizzera 69
CL - Cile 68
CZ - Repubblica Ceca 60
PT - Portogallo 56
RO - Romania 47
SA - Arabia Saudita 46
TH - Thailandia 46
EU - Europa 42
NO - Norvegia 41
EG - Egitto 34
IL - Israele 34
PE - Perù 32
PH - Filippine 30
IR - Iran 26
DZ - Algeria 25
MA - Marocco 24
LY - Libia 23
HU - Ungheria 22
EC - Ecuador 20
AT - Austria 18
MY - Malesia 18
HR - Croazia 16
RS - Serbia 16
SK - Slovacchia (Repubblica Slovacca) 14
LT - Lituania 12
TN - Tunisia 12
BD - Bangladesh 11
NZ - Nuova Zelanda 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
CR - Costa Rica 8
SI - Slovenia 8
ZA - Sudafrica 8
BY - Bielorussia 7
JO - Giordania 7
KZ - Kazakistan 7
PK - Pakistan 7
BF - Burkina Faso 6
BO - Bolivia 6
IS - Islanda 6
MO - Macao, regione amministrativa speciale della Cina 6
SR - Suriname 6
VE - Venezuela 6
CU - Cuba 5
ET - Etiopia 5
SC - Seychelles 5
UY - Uruguay 5
UZ - Uzbekistan 5
AM - Armenia 4
EE - Estonia 4
IQ - Iraq 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
AP - ???statistics.table.value.countryCode.AP??? 3
BA - Bosnia-Erzegovina 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
LB - Libano 3
MK - Macedonia 3
MT - Malta 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
RE - Reunion 3
SN - Senegal 3
BH - Bahrain 2
Totale 23.612
Città #
Southend 1.503
Fairfield 1.428
Princeton 871
Dublin 801
Ashburn 751
Seattle 737
Wilmington 724
Woodbridge 701
Houston 564
Chandler 509
Cambridge 501
Redwood City 464
Milan 426
Beijing 354
Des Moines 318
Ann Arbor 315
Central District 255
Bengaluru 226
Jinan 159
Dearborn 142
Phoenix 123
Nanjing 113
Shanghai 107
Shenyang 106
Tokyo 105
San Diego 101
Toronto 93
Hong Kong 91
New York 80
Guangzhou 71
Hangzhou 69
London 67
Frankfurt am Main 61
Paris 61
Ankara 58
Jacksonville 58
Zhengzhou 57
Istanbul 55
Madrid 55
Changsha 54
Hebei 54
Athens 52
Hefei 52
Redmond 51
Seoul 50
Ottawa 48
Chicago 47
Silver Spring 47
Rome 46
Berlin 45
Mountain View 44
Dong Ket 43
Wuhan 43
Boardman 42
Buenos Aires 41
Grafing 39
Guadalajara 39
Nanchang 39
Taiyuan 39
Taipei 38
Helsinki 37
Florence 36
Santiago 36
São Paulo 36
Haikou 35
Bogotá 32
Kunming 32
Tianjin 32
Prague 31
Sakarya 31
Bangkok 29
Chengdu 29
Duncan 29
Falls Church 29
Brussels 28
Nuremberg 27
Barcelona 26
Izmir 26
Norwalk 26
Serra 26
Atlanta 25
Lima 25
Eitensheim 24
Los Angeles 24
Medellín 24
Bethesda 23
Taizhou 23
Delhi 22
Montreal 22
Andover 21
Durham 21
Hyderabad 21
Naples 21
Pisa 21
Warsaw 21
Amsterdam 20
Cincinnati 20
Philadelphia 20
Singapore 20
Turin 20
Totale 15.284
Nome #
Current and emerging biologics for the treatment of juvenile idiopathic arthritis 1.335
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 1.213
Blau syndrome : cross-sectional data from a multicentre study of clinical, radiological and functional outcomes 603
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease : a retrospective cases series 531
Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic 412
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's) : an ARChiVe Cohort Study 296
Current evidence of methotrexate efficacy in childhood chronic uveitis : a systematic review and meta-analysis approach 283
Adalimumab in the treatment of immune-mediated diseases 258
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis 235
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated with Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities 213
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 210
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis : 1-year followup data from the Italian Registry 195
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 194
Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus 187
Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis 183
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis 179
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases : focus on adalimumab 177
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome 172
Gut microbiota in children and altered profiles in juvenile idiopathic arthritis 167
Anti-inflammatory and immunosuppressive drugs and reproduction 163
COVID-19 infection and rheumatoid arthritis: Faraway, so close! 162
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 159
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 157
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases 157
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs 148
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 147
Registries in rheumatological and musculoskeletal conditions : Paediatric Behçet's disease: an international cohort study of 110 patients : one-year follow-up data 146
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 139
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 136
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 128
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects 124
Methotrexate in juvenile idiopathic arthritis : advice and recommendations from the MARAJIA expert consensus meeting 123
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review 123
Systemic-onset juvenile idiopathic arthritis : the changing life of a rare disease 122
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 120
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero 118
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation collaborative initiative 118
Early joint replacement in juvenile idiopathic arthritis (JIA): trend over time and factors influencing implant survival 118
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 117
Canakinumab for Childhood Sight-threatening Refractory Uveitis : a Case Series 116
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 114
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis : associations with HLA-B27 Allele and Disease Status 114
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 113
Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies 112
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 111
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy 107
COVID-19 and what pediatric rheumatologists should know: A review from a highly affected country 107
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets 106
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 104
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis 104
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy 103
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis : Results From a Phase III Open-Label Study 103
Th17 cells that undergo plasticity to a Th1 phenotype in human autoimmune arthritis can be detected by the expression of CD161 within the inflamed joint 102
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells 101
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion 100
Is cervical spine involvement in juvenile polyarthritis under-recognized? 99
Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: Comment on the article by Costedoat-Chalumeau et al 98
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug : Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis 98
Impact of in utero environment on the offspring of lupus patients 97
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 97
Recurrent Pericarditis in Children and Adolescents 97
Pediatric antiphospholipid syndrome : clinical and immunologic features of 121 patients in an international registry 96
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 96
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists : a Nationwide Multi-Center Retrospective Observational Study 96
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 96
Extensive ethnic variation and linkage disequilibrium at the FCGR2/3 locus : different genetic associations revealed in Kawasaki disease 95
Clinical and transcriptional response to the long‐acting interleukin‐1 blocker canakinumab in Blau syndrome–related uveitis 94
Different histological classifications for Henoch-Schönlein purpura nephritis : which one should be used? 94
QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block 93
Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic 93
Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis 92
Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome) 91
High prevalence of HGV/GBV-C infection in polytransfused patients with thalassemia major 91
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 91
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 91
Prevention of flare recurrences in childhood-refractory chronic uveitis : an open-label comparative study of adalimumab versus infliximab 90
Kawasaki disease in Sicily : clinical description and markers of disease severity 89
Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis 89
Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis : results of a 10-year prospective study 88
Elicitation of expert prior opinion : application to the MYPAN trial in childhood polyarteritis nodosa 88
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 88
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment 87
Kawasaki disease : an epidemiological study in central Italy 87
Monogenic forms of systemic lupus erythematosus : new insights into SLE pathogenesis 87
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation : a series of 158 cases from the Eurofever/EUROTRAPS international registry 86
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 86
The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis 86
Sixth meeting of the European Forum on antiphospholipid antibodies : how to improve the understanding of the antiphospholipid syndrome? 85
Psoriatic juvenile idiopathic arthritis associated with uveitis : a case report 85
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 85
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells 85
Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings 85
Osteoporosis 84
Congenital heart block not associated with anti-Ro/La antibodies: Comparison with anti-Ro/La-positive cases 84
Common symptoms for a rare disease in a girl with sarcoidosis : a case report 84
Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis 84
Arthritis and infections 82
Treatment of autoinflammatory diseases : results from the Eurofever Registry and a literature review 82
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 82
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 82
Totale 15.520
Categoria #
all - tutte 71.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019186 0 0 0 0 0 0 0 0 0 62 69 55
2019/20207.147 414 386 269 1.525 628 583 613 519 767 634 520 289
2020/20215.252 432 583 318 278 544 773 309 601 413 321 355 325
2021/20224.073 248 245 228 222 296 190 233 332 383 438 317 941
2022/20234.387 640 285 307 366 309 983 214 263 398 147 280 195
2023/20243.247 217 332 262 332 704 405 232 321 190 252 0 0
Totale 25.877